InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.91
(
0.01%
)
US TECH 100
19,852.80
(
0.03%
)
Dow Jones
39,330.39
(
-0.12%
)
Brent Oil
85.32
(
-1.37%
)
Bitcoin
56,233.77
(
0.69%
)
Post# of 23979
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

buckiii2

Send PM Follow Ignore
Followers 59
Posts 4696
Boards Moderated 0
Alias Born 04/27/2009

buckiii2

Re: None

Thursday, 08/25/2016 5:06:33 PM

Thursday, August 25, 2016 5:06:33 PM

Post# of 23979
Roth Capital Affirms BioBlast Pharma (ORPN) at 'Buy'; Sees Trehalose Plan Heading in Right Direction

August 25, 2016 11:13 AM
Roth Capital affirms BioBlast Pharma (Nasdaq: ORPN) with a Buy rating and $15 price target following Q2 results released earlier ...
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up